184 related articles for article (PubMed ID: 36382664)
1. LncRNA DDX11-AS1 Promotes Chemoresistance through LIN28A-Mediated ATG12 mRNA Stabilization in Breast Cancer.
Si X; Zhang G; Li M; Yao M; Shi X; Dong Z; Gao S
Pharmacology; 2023; 108(1):61-73. PubMed ID: 36382664
[TBL] [Abstract][Full Text] [Related]
2. The long non-coding RNA DDX11-AS1 facilitates cell progression and oxaliplatin resistance via regulating miR-326/IRS1 axis in gastric cancer.
Song W; Qian Y; Zhang MH; Wang H; Wen X; Yang XZ; Dai WJ
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3049-3061. PubMed ID: 32271422
[TBL] [Abstract][Full Text] [Related]
3. LncRNA DDX11-AS1 promotes cell growth, migration and invasion through regulating epithelial-mesenchymal transition in breast cancer.
Xi X; Yang F; Ding Z; Zhuang H; Yuan H
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):40-44. PubMed ID: 38678629
[TBL] [Abstract][Full Text] [Related]
4. LncRNA OIP5-AS1 Promotes the Autophagy-Related Imatinib Resistance in Chronic Myeloid Leukemia Cells by Regulating miR-30e-5p/ATG12 Axis.
Dai H; Wang J; Huang Z; Zhang H; Wang X; Li Q; Feng W
Technol Cancer Res Treat; 2021; 20():15330338211052150. PubMed ID: 34723728
[No Abstract] [Full Text] [Related]
5.
Liu J; Yang X; Gao S; Wen M; Yu Q
Pharmacogenomics; 2023 Feb; 24(3):163-172. PubMed ID: 36779347
[No Abstract] [Full Text] [Related]
6. Long noncoding RNA DDX11-AS1 epigenetically represses LATS2 by interacting with EZH2 and DNMT1 in hepatocellular carcinoma.
Li Y; Zhuang W; Huang M; Li X
Biochem Biophys Res Commun; 2019 Jul; 514(4):1051-1057. PubMed ID: 31097223
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA DDX11-AS1 facilitates gastric cancer progression by regulating miR-873-5p/SPC18 axis.
Ren Z; Liu X; Si Y; Yang D
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):572-583. PubMed ID: 32054332
[TBL] [Abstract][Full Text] [Related]
8. DDX11-AS1 contributes to osteosarcoma progression via stabilizing DDX11.
Zhang H; Lin J; Chen J; Gu W; Mao Y; Wang H; Zhang Y; Liu W
Life Sci; 2020 Aug; 254():117392. PubMed ID: 32014424
[TBL] [Abstract][Full Text] [Related]
9. LncRNA DDX11-AS1: a novel oncogene in human cancer.
Feng Y; Wu M; Hu S; Peng X; Chen F
Hum Cell; 2020 Oct; 33(4):946-953. PubMed ID: 32772230
[TBL] [Abstract][Full Text] [Related]
10. Landscape analysis of lncRNAs shows that DDX11-AS1 promotes cell-cycle progression in liver cancer through the PARP1/p53 axis.
Xu M; Zhao X; Zhao S; Yang Z; Yuan W; Han H; Zhang B; Zhou L; Zheng S; Li MD
Cancer Lett; 2021 Nov; 520():282-294. PubMed ID: 34371129
[TBL] [Abstract][Full Text] [Related]
11. LncRNA DDX11-AS1 accelerates hepatocellular carcinoma progression via the miR-195-5p/MACC1 pathway.
Wan T; Zheng J; Yao R; Yang S; Zheng W; Zhou P
Ann Hepatol; 2021; 20():100258. PubMed ID: 32961346
[TBL] [Abstract][Full Text] [Related]
12. LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway.
Zhang M; Wang Y; Jiang L; Song X; Zheng A; Gao H; Wei M; Zhao L
J Exp Clin Cancer Res; 2021 Jan; 40(1):41. PubMed ID: 33494806
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA DDX11-AS1 promotes esophageal carcinoma cell proliferation and migration through regulating the miR-514b-3p/RBX1 axis.
Wu C; Wang Z; Tian X; Wang J; Zhang Y; Wu B
Bioengineered; 2021 Dec; 12(1):3772-3786. PubMed ID: 34281459
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of long non‑coding RNA DDX11‑AS1 inhibits the proliferation, migration and paclitaxel resistance of breast cancer cells by upregulating microRNA‑497 expression.
Liang M; Zhu B; Wang M; Jin J
Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35169864
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA DDX11-AS1 induced by YY1 accelerates colorectal cancer progression through targeting miR-873/CLDN7 axis.
Tian JB; Cao L; Dong GL
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5714-5729. PubMed ID: 31298324
[TBL] [Abstract][Full Text] [Related]
16. LncRNA
Chen D; Chen J; Gao J; Zhang Y; Ma Y; Wei W; Wei Y
Cancer Biother Radiopharm; 2020 Jun; 35(5):319-328. PubMed ID: 32412777
[No Abstract] [Full Text] [Related]
17. LncRNA DDX11 antisense RNA 1 promotes EMT process of esophageal squamous cell carcinoma by sponging miR-30d-5p to regulate SNAI1/ZEB2 expression and Wnt/β-catenin pathway.
Guo Y; Sun P; Guo W; Yin Q; Han J; Sheng S; Liang J; Dong Z
Bioengineered; 2021 Dec; 12(2):11425-11440. PubMed ID: 34866524
[TBL] [Abstract][Full Text] [Related]
18. N
Huang T; Cao L; Feng N; Xu B; Dong Y; Wang M
Bioengineered; 2021 Dec; 12(2):10935-10944. PubMed ID: 34866525
[TBL] [Abstract][Full Text] [Related]
19. SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88.
Dong H; Wang W; Mo S; Chen R; Zou K; Han J; Zhang F; Hu J
J Exp Clin Cancer Res; 2018 Aug; 37(1):202. PubMed ID: 30157918
[TBL] [Abstract][Full Text] [Related]
20. A1BG-AS1 promotes adriamycin resistance of breast cancer by recruiting IGF2BP2 to upregulate ABCB1 in an m6A-dependent manner.
Wang J; Xu J; Zheng J
Sci Rep; 2023 Nov; 13(1):20730. PubMed ID: 38007504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
